Article Text

Download PDFPDF
Jaundice in non-cirrhotic primary biliary cirrhosis: the premature ductopenic variant
  1. F P Vleggaara,
  2. H R van Buurena,
  3. P E Zondervanb,
  4. F J W ten Katec,
  5. W C J Hopd,
  6. the Dutch Multicentre PBC study group
  1. aDepartment of Gastroenterology and Hepatology, University Hospital Rotterdam, the Netherlands, bDepartment of Pathology, University Hospital Rotterdam, the Netherlands, cDepartment of Pathology, Academic Medical Centre, Amsterdam, the Netherlands, dDepartment of Epidemiology and Biostatistics, Erasmus University Rotterdam, the Netherlands
  1. H R van Buuren, Department of Gastroenterology and Hepatology, University Hospital Rotterdam, PO Box 2040, 3000 CA, Rotterdam, the Netherlands.devlaming{at}mdl.azr.nl

Abstract

The clinical and pathological findings of four females with primary biliary cirrhosis (PBC) with an unusual and hitherto not well recognised course are reported. Patients suffered severe pruritus and weight loss with progressive icteric cholestasis which did not respond to such treatments as ursodeoxycholic acid and immunosuppressives. In all cases liver histology revealed marked bile duct loss without however significant fibrosis or cirrhosis. Further diagnostic studies and repeat biopsies confirmed the absence of liver cirrhosis as well as other potential causes of hyperbilirubinaemia. Comparison of the fibrosis-ductopenia relationship for our cases with that for a group of 101 non-cirrhotic PBC patients indicated that in the former the severity of bile duct loss relative to the amount of fibrosis was significantly higher. The proportion of portal triads containing an interlobular bile duct was 3%, 4%, 6%, and 10% compared with 45% (median; range 8.3–100%) for controls (p<0.001). Three patients received a liver transplant 6–7 years after the first manifestation of PBC because of progressive cholestasis, refractory pruritus, and weight loss, while the fourth patient is considering this option. In one case cirrhosis had developed at the time of transplantation while the others still had non-cirrhotic disease. These cases suggest that cholestatic jaundice in non-cirrhotic PBC may be secondary to extensive “premature” or accelerated intrahepatic bile duct loss. Although the extent of fibrosis may be limited initially, progression to cirrhosis appears to be inevitable in the long run. Despite intact protein synthesis and absence of cirrhotic complications, liver transplantation in the pre-cirrhotic stage for preventing malnutrition and to improve quality of life should be considered for these patients.

  • primary biliary cirrhosis
  • jaundice
  • ductopenia
  • portal tract
  • cholestasis
  • liver biopsy
  • Abbreviations used in this paper

    PBC
    primary biliary cirrhosis
    AMA
    antimitochondrial antibody
    UDCA
    ursodeoxycholic acid
  • Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

  • Abbreviations used in this paper

    PBC
    primary biliary cirrhosis
    AMA
    antimitochondrial antibody
    UDCA
    ursodeoxycholic acid
  • View Full Text